|
Originally published In Press as doi:10.1074/jbc.M005366200 on August 1, 2000
J. Biol. Chem., Vol. 275, Issue 42, 32516-32522, October 20, 2000
Vanadate Induces p53 Transactivation through Hydrogen Peroxide
and Causes Apoptosis*
Chuanshu
Huang,
Zhuo
Zhang,
Min
Ding,
Jingxia
Li,
Jianping
Ye,
Stephen S.
Leonard,
Han-Ming
Shen,
Leon
Butterworth,
Yongju
Lu,
Max
Costa ,
Yongyut
Rojanasakul§,
Vincent
Castranova,
Val
Vallyathan, and
Xianglin
Shi¶
From the Health Effects Laboratory Division, National Institute for
Occupational Safety and Health, Morgantown, West Virginia 26505, the
Nelson Institute of Environmental Medicine and Kaplan
Comprehensive Cancer Center, New York University School of
Medicine, New York, New York 10016, and the § Department
of Basic Pharmaceutical Science, West Virginia University,
Morgantown, West Virginia 26506
Received for publication, June 20, 2000, and in revised form, July 20, 2000
 |
ABSTRACT |
Vanadium is a metal widely distributed in the
environment. Although vanadate-containing compounds exert potent toxic
effects on a wide variety of biological systems, the mechanisms
controlling vanadate-induced adverse effects remain to be elucidated.
The present study investigated the vanadate-induced p53 activation and
involvement of reactive oxygen species (ROS) in p53 activation as well
as the role of p53 in apoptosis induction by vanadate. Exposure of
mouse epidermal JB6 cells to vanadate led to transactivation of p53
activity in a time- and dose-dependent manner. It also caused mitochondrial damage, apoptosis, and generated ROS. Scavenging of vanadate-induced H2O2 by
N-acetyl-L-cysteine (a general antioxidant) or
catalase (a specific H2O2 inhibitor), or the
chelation of vanadate by deferoxamine, resulted in inhibition of p53
activation and cell mitochondrial damage. In contract, an increase in
H2O2 generation in response to superoxide
dismutase or NADPH enhanced these effects caused by vanadate.
Furthermore, vanadate-induced apoptosis occurred in cells expressing
wild-type p53 (p53+/+) but was very weak in p53-deficient (p53 / )
cells. These results demonstrate that vanadate induces p53 activation
mainly through H2O2 generation, and this activation is required for vanadate-induced apoptosis.
 |
INTRODUCTION |
The p53 tumor suppressor protein is a transcription factor that
enhances the transcriptional rate of several genes known to play a
critical role in transducing signals from DNA damage (1-5). It is
elevated in response to genotoxic agents, such as ionizing radiation,
UV light, or certain chemicals (1, 4, 6). The activation of p53 has
been implicated in cell cycle control, DNA repair, and apoptosis
(5-7). The function of p53 is regulated at the levels of
transcription, translation, protein turnover, and cellular
compartmentalization, as well as association with other proteins (8).
In addition, growing evidence indicates that the ability of p53 to
inhibit diverse regulatory functions is likely to depend on its
phosphorylation, which is conformation-dependent (8, 9).
p53 phosphorylation is mediated by a variety of protein kinases,
including casein kinase I, casein kinase II, protein kinase A, CDK7,
DNA-activated protein kinase, protein kinase C, c-Jun
NH2-terminal kinases, extracellular signal-regulated kinases, and p38 kinase (8-10).
Apoptosis, or programmed cell death, has been characterized as a
fundamental cellular activity occurring under a wide range of
physiological and pathological conditions (1-4, 11, 12). It is
essential in many physiological processes, including maturation and
effector mechanisms of the immune system, embryonic development, and
hormone-dependent tissue remodeling (11-15). Inappropriate regulation of apoptosis may play an important role in many pathological conditions such as hepatotoxicity, ischemia, stroke, heart disease, cancer, AIDS, autoimmunity, and degenerative diseases of the central nervous system (16-18).
Vanadium is a transition metal widely distributed in environment.
Occupational exposure to vanadium is common in oil-fired electrical
generating plants and the petrochemical, steel, and mining industries
(19, 20). It has been found that vanadate-containing compounds exert
potent toxic and carcinogenic effects, such as DNA damage and cell
transformation (21-23). Normally, if the cell is damaged by external
agents, such as vanadate, it will respond to such damage by activating
signal transduction pathways that control the activation of
transcription factors and the regulation of gene expression as well as
transiently delaying cell cycle progression to allow the repair of
damaged DNA. If the cell damage is severe and cannot be repaired, the
cells will undergo apoptosis. Therefore, apoptosis plays an
essential role as a protective mechanism against neoplastic development
in the organism by eliminating genetically damaged or improperly
proliferating cells. Investigation of the mechanism of
carcinogen-induced apoptosis is very important for understanding
overall carcinogenesis. It has been demonstrated that vanadate-mediated
generation of reactive oxygen species
(ROS)1 plays an important
role in its adverse biological effects (24-27). Our previous studies
also indicate that generation of H2O2 by vanadate is a mediator for apoptosis induction in a cell culture model
(24). The present study investigated the p53 transactivation and its
mechanisms as well as its role in apoptosis induction by vanadate.
 |
MATERIALS AND METHODS |
Reagents--
Sodium metavanadate (vanadate) was purchased from
Aldrich; deferoxamine, N-acetyl-L-cysteine
(NAC), NADPH, superoxide dismutase (SOD), and sodium formate were
purchased from Sigma; JC-1, DiOC6, DCFH-DA, and
dihydroethidium (HE) were purchased from Molecular Probes (Eugene, OR);
luciferase assay substrate was obtained from Promega; fetal bovine
serum (FBS), Eagle's minimal essential medium (MEM), and Dulbecco's
modified Eagle's medium, as well as RPMI 1640 were from BioWhittaker.
Cell Culture--
The JB6 P+ mouse epidermal cell
line (Cl 41) and its stable p53 luciferase reporter plasmid
transfectant (Cl 41 p53 cells) were cultured in monolayers at 37 °C
under 5% CO2 using MEM containing 5% fetal calf serum, 2 mM L-glutamine, and 25 µg/ml gentamicin (28-30). Normal embryo fibroblasts (p53+/+) or p53-deficient embryo fibroblasts (p53 / ) were cultured in Dulbecco's modified Eagle's medium with 10% FBS, 2 mM L-glutamine, and 25 µg/ml gentamicin (31).
Assay for p53 Activity--
Confluent monolayers of Cl 41 p53 cells were trypsinized, and 8 × 103 viable cells
were suspended in 100 µl 5% FBS/MEM. The cells were added into each
well of a 96-well plate. Plates were incubated at 37 °C in a
humidified atmosphere of 5% CO2. Twelve to 24 h later, cells were starved by culturing them in 0.1% FBS/MEM for 12 h. The cells were exposed for 24 h to different
concentrations of vanadate for p53 induction. The cells were extracted
with lysis buffer, and luciferase activity was measured using a
luminometer (Monolight 3010). The results were expressed as p53
activity relative to controls (5, 6, 30).
DNA Fragmentation Assay--
Cl 41 cells were exposed to
ultraviolet C (60 J/m2) or treated with different
concentrations of vanadate for 24 h. All the cells were harvested
by centrifugation and lysed with a lysis buffer (5 mM
Tris-HCl, pH 8.0; 20 mM EDTA; 0.5% Triton X-100) on ice
for 45 min. Fragmented DNA in the supernatant (after a centrifugation
at 14,000 rpm for 30 min at 4 °C) was extracted twice with
phenol/chloroform/isoamyl alcohol (25:24:1, v/v/v) and once with
chloroform before precipitating with ethanol and salt. The DNA pellet
was washed once with 70% ethanol and resuspended in TE buffer, pH 8.0, with 100 µg/ml RNase at 37 °C for 2 h. The DNA fragments were
separated by 1.8% agarose gel electrophoresis and visualized under UV
light as described previously (5, 6).
DNA Fragment End Labeling Assay--
The cells were treated with
vanadate for 24 h. The cells were then harvested. The DNA fragment
end labeling assays were performed as described in the protocol by the
manufacturer using an in situ cell death detection kit
employing fluorescein (Roche Molecular Biochemicals). The cells were
analyzed by flow cytometry.
Mitochondria Transmembrane Potential ( m)
Assay--
JC-1 and DiOC6 are two specific fluorescent
dyes used to test the cell mitochondrial membrane potential (32). The
cells were seeded in 6-well plates and cultured until 90% confluent. The cells were then treated with vanadate for 12 h. The dye, JC-1 or DiOC6 (dissolved in Me2SO and diluted
with PBS to final concentrations of 10 µg/ml or 40 nM,
respectively), was applied to the cells and incubated for another
15-20 min at 37 °C. The cells were washed twice with PBS and
harvested for analysis by flow cytometry.
Cellular Superoxide (O 2) and
H2O2 Staining Assay--
HE is a specific
O 2 dye (32), and DCFH-DA has been frequently used to monitor
H2O2 levels in cells (32). The cells were seeded in 6-well plates and cultured until 90% confluent. The cells
were then treated with vanadate for 12 h. HE or DCFH-DA (both
dissolved in Me2SO and diluted with PBS to final
concentrations of 5 and 5 µM, respectively) was applied
to the cells and incubated for another 15-20 min at 37 °C. The
cells were washed twice with PBS and harvested for analysis by flow cytometry.
Electron Spin Resonance (ESR) Measurements--
ESR measurements
were carried out using a Varian E9 ESR spectrometer and a flat cell
assembly. Hyperfine couplings were measured (0.1 G) directly from
magnetic field separation using potassium tetraperoxochromate
(K3CrO8) and
1,1-diphenyl-2-picrylhydrazyl as reference standards. Cl41 cells
(1 × 106) were mixed with 100 mM
5,5-dimethyl-1-pyrroline N-oxide, 100 µM NADPH, and 1 mM vanadate. The reaction
mixture was then transferred to a flat cell for ESR measurement as
described previously (19, 26).
 |
RESULTS |
Activation of p53 Transactivation Activity by Vanadate--
To
investigate the possible activation of p53 by vanadate, we exposed the
well characterized JB6 cell with PG13-luciferase reporter stable
transfectants to vanadate (5, 6, 30). The results show that vanadate
markedly activated p53-dependent transcription activity in
a time- and dose-dependent manner (Fig. 1). The maximum induction of p53 activity
occurred between 36 and 48 h after cell exposed to vanadate (Fig.
1B). These results demonstrated that vanadate is a stimulus
for p53 transactivation. It may noted that these data are different
from previous reports that indicate that at a concentration of 1 mM, vanadate decreased (35), whereas at a concentration of
10 µM, vanadate did not exhibit any observable (36)
effects on p53 mRNA levels in human cancer HeLa cells and C127
mouse tumor cells, respectively. These differences may be due to
different cell lines and doses used among these studies. This was
supported by our study that 10 µM vanadate had no effects
on p53 activity in JB6 cells (data not shown).

View larger version (11K):
[in this window]
[in a new window]
|
Fig. 1.
Induction of p53-dependent
transcription activity by vanadate. JB6, Cl 41, and
PG13-luciferase (PG13-luc) stable transfectant (Cl 41 p53) cells,
suspended in 5% FBS/MEM, were added to each well of 96-well plates and
cultured overnight. A, for the dose-response study, the
cells were treated for 30 h with vanadate at the concentrations
indicated. B, for time course study, the cells were treated
with 200 µM vanadate for various time points as
indicated. The asterisk indicates a significant increase
from control (p < 0.05). p53 activity was determined
by the luciferase activity assay. The results are presented as relative
p53 activity. Each point and bar indicates the
mean ± S.D. from triplicate assays.
|
|
Generation of Reactive Oxygen Species Is Required for p53
Activation by Vanadate--
It has been reported that vanadate may
generate ROS under some circumstances (24). To study the
relationship between ROS generation and p53 activation,
vanadate-induced ROS production was determined either by dye staining
or ESR. Fig. 2A showed that cells alone did not generate any detectable amount of free radicals, whereas a mixture of cells and vanadate generated a strong ESR spectrum
(Fig. 2B). The spectrum consists of a 1:2:2:1 quartet with
hyperfine splittings of aH = aN = 14.9 G, where aN and
aH denote hyperfine splittings of the nitroxyl
nitrogens and -hydrogen, respectively. Based on these splittings and
the 1:2:2:1 line shape, the spectrum was assigned to the DMPO-OH
adduct, which is evidence of ·OH radical generation. Addition of
catalase, a scavenger of H2O2, inhibited
·OH radical generation (Fig. 2C), indicating that
H2O2 was produced in the vanadate-treated cells
and served as a precursor of ·OH generation. Addition of sodium
formate, an ·OH radical scavenger, decreased the signal
intensity (Fig. 2D), confirming that the 1:2:2:1 quartet
observed in this study was due to ·OH generation. Incubation of
the mixture with deferoxamine, a metal chelator, dramatically decreased
the signal intensity (Fig. 2E), indicating a key role of
vanadate in the radical generation. Measurements using HE, a specific
fluorescent dye for O 2, or DCFH-DA, a fluorescent dye for
H2O2, demonstrate that incubation of cells with
vanadate led to an increase in the generation of both O 2
(increasing percentage of positive cells from 48.7 to 75.2%) and
H2O2 (increasing percentage of positive cells
from 50.4 to 63.5%) (Figs. 3,
A and B). To investigate the possible role of ROS
in p53 activation by vanadate, the effect of specific modifiers of ROS
on vanadate-induced p53 activation was determined. The results show
that pretreatment of cells with NAC, catalase, or deferoxamine caused
inhibition of vanadate-induced p53 activation (p < 0.05) (Fig. 4), whereas increasing
H2O2 generation with the addition of SOD or
NADPH enhanced p53 activation (p < 0.05) (Fig. 4).
These effects on vanadate-induced p53 activation are consistent with
the effects on ROS generation (Fig. 2). These data support the
hypothesis that ROS generation by vanadate is required for its
activation of p53. It is noted that treatment of cell with sodium
formate not only did not inhibits vanadate-induced p53 activation but
also enhanced vanadate-induced p53 activation (Fig. 4).

View larger version (14K):
[in this window]
[in a new window]
|
Fig. 2.
Measurement of vanadate-induced ROS
generation by ESR. ESR spectra were recorded 6 min after mixing
1 × 106 Cl 41 cells, 100 mM
5,5-dimethyl-1-pyrroline N-oxide, 1 mM
sodium vanadate, and 100 µM NADPH with or without
different ROS scavengers as indicated. The final concentrations of
these scavengers were catalase, 2000 units/ml; SOD, 0.5 µg/ml; or
sodium formate, 100 mM. Deferoxamine, 2 mM, was
used as a metal chelator.
|
|

View larger version (24K):
[in this window]
[in a new window]
|
Fig. 3.
Determination of O 2 and
H2O2 by HE and DCFH-DA staining. Cl 41 cells were seeded in 6-well plates and cultured until 90% confluent.
The cells were then treated with vanadate for 60 min. HE (A)
or DCFH-DA (B) was applied to the cells and incubated for
another 15-20 min at 37 °C. The cells were washed twice with PBS
and harvested for analysis by flow cytometry. a and
c are HE and DCFH-DA controls, respectively; b
and d are cells with 200 µM vanadate
treatment.
|
|

View larger version (28K):
[in this window]
[in a new window]
|
Fig. 4.
Effects of free radical scavengers on p53
activation by vanadate. JB6, Cl 41, and PG13-luciferase (PG13-luc)
stable transfectant (Cl 41 p53) cells suspended in 5% FBS/MEM were
added to each well of 96-well plates and cultured overnight. The cells
were pretreated with different free radical modifiers at the
concentrations indicated. The cells were then exposed to vanadate (100 µM) for 24 h. The p53 activity was determined by the
luciferase activity assay. The results are presented as relative p53
activity. Each column and bar indicates the
mean ± S.D. from triplicate assays. The * indicates a significant
increase from control; indicates a significant decrease from
vanadate; and ** indicates a significant increase from vanadate
(p < 0.05).
|
|
Induction of Apoptosis by Vanadate--
p53 is believed to
be crucial in the induction of apoptosis in human and murine cells
following DNA damage (5, 6, 8). This notion was supported by the
findings that apoptosis of both thymocytes and intestinal crypt cells
following irradiation was blocked in p53-deficient mice (5, 6, 37, 38).
To study the molecular basis of vanadate-induced apoptosis, we
established an apoptosis model using JB6 Cl 41 cells. The results from
DNA fragmentation assay showed that treatment of cells with vanadate indeed caused a dose-dependent induction of apoptosis in Cl
41 cells (Figs. 5A). Flow
cytometric analysis of DNA fragment end labeling indicated that
apoptosis increased by 11.6, 38.2, and 51.8% at the concentrations of
50, 100, and 400 µM, respectively (Fig. 5B),
whereas the control group only had 3.0% positive cells. It was noted
that apoptosis induction at 400 µM vanadate was higher than that at 200 µM, whereas p53 activation at 400 µM is less than that at 200 µM. The
explanation for this is that there were more apoptotic cells at 400 µM than at 200 µM, which resulted in less
p53 activity observed at 400 µM. Exposure of the human lung cell line (A549) to 200 µM vanadate also increased
apoptosis by 35.6% (Fig. 5C). These results suggest that
vanadate-induced apoptosis is not only limited in mouse epidermal Cl 41 cells.

View larger version (35K):
[in this window]
[in a new window]
|
Fig. 5.
Induction of apoptosis by vanadate.
A and B, subconfluent (80-90%) monolayers of
JB6 Cl 41 cells in 100-mm dishes were subjected to either ultraviolet C
(UVC) (120 J/m2, positive control) or different
concentrations of vanadate for 30 h. Then both detached and
attached cells were harvested. A, DNA fragmentation assays
were carried out as described under "Materials and Methods";
B, DNA fragment end labeling assays were performed as
described using an in situ cell death detection kit
employing fluorescein (Roche Molecular Biochemicals). The cells were
analyzed by flow cytometry. The concentrations of vanadate used were as
follows: a, medium control; b, 50 µM; c, 100 µM; and d,
400 µM. C, A549 cells were treated with
vanadate for 30 h. The cells were harvested, and DNA fragment end
labeling assays were carried out using the same method described in
B. The concentrations of vanadate used were as follows:
a, medium control; b, 200 µM
vanadate.
|
|
Induction of Mitochondrial Damage by Vanadate--
Mitochondrial
damage is a key step for apoptosis in many experimental systems
(32-34). Changes of mitochondrial transmembrane potential
( m) have been considered an indicator of mitochondrial
damage (32-34). JC-1 and DiOC6 are two dyes widely used
for determination of  m (32-34). We employed these dyes
and found that treatment of cells with vanadate resulted in a
significant decrease in  m as measured by JC-1 staining
(from 61.6 to 19.3%) and DiOC6 staining (from 38.9 to 6.0%) (Fig. 6). These data indicate that
vanadate causes mitochondrial membrane damage.

View larger version (26K):
[in this window]
[in a new window]
|
Fig. 6.
Mitochondrial damage induced by
vanadate. Cl 41 cells were seeded in 6-well plates and
cultured until 90% confluent. The cells were then treated with
vanadate for 12 h. The dye JC-1 (A) or
DiOC6 (B) dissolved in Me2SO and
diluted with PBS to final concentrations of 10 µg/ml or 40 nM, respectively, was applied to the cells and incubated
for another 15-20 min at 37 °C. The cells were washed twice with
PBS and harvested for analysis by flow cytometry. a and
c are JC-1 and DiOC6 controls, respectively, and
b and d are cells treated with 200 µM vanadate.
|
|
ROS-mediated p53 Activation Plays an Essential Role in
Mitochondrial Damage and Apoptosis by Vanadate--
To study the
ROS-mediated p53 activation in vanadate-induced mitochondrial damage,
the cells were preincubated with various ROS modifiers for 30 min, and
then the cells were used to study mitochondrial damage in response to
vanadate. As shown in Fig. 7, the effects
of these ROS modifiers on  m changes are in agreement with
their effects on vanadate-induced p53 activation (Fig. 7).

View larger version (29K):
[in this window]
[in a new window]
|
Fig. 7.
Effects of free radical modifiers on the
decrease in mitochondrial transmembrane potential induced by
vanadate. Cl 41 cells suspended in 5% FBS/MEM were added to each
well of 6-well plates and cultured overnight. The cells were pretreated
with different free radical modifiers as indicated for 30 min. The
final concentrations of these modifiers are as follows: catalase,
5 × 104 units/ml; SOD, 250 units/ml; sodium formate,
300 µM; or deferoxamine, 2 mM. The cells were
exposed to vanadate at 200 µM for 12 h. The dye JC-1
was applied to the cells at a final concentration of 10 µg/ml. The
cells were incubated for another 15-20 min at 37 °C, washed twice
with PBS, and then harvested for analysis flow cytometry. The
percentages of positive cells are as follows: a, 40.7% for
JC-1 control; b, 24.8% for vanadate; c, 45.1%
for vanadate + deferoxamine; d, 8.3% for vanadate + SOD;
e, 33.6% for vanadate + catalase; and f, 23.5%
for vanadate + sodium formate.
|
|
To obtain direct evidence for the involvement of ROS-mediated p53
activation in vanadate-induced apoptosis, we used two fibroblast cell
lines, p53+/+ and p53 / , which were derived from mouse embryos containing either wild-type p53 (p53+/+) or were p53-deficient (p53 / ) as reported previously (5, 6, 31). p53+/+ fibroblasts exhibited increases of apoptosis by 41.6, 36.6, and 25.7% at vanadate doses of 800, 200, or 50 µM, respectively, whereas
p53 / cells showed very weak responses (16.0, 9.0, and 0.0% at
vanadate doses of 800, 200, or 50 µM, respectively) (Fig.
8). These results demonstrate that p53
activation mediated by H2O2 is required for
vanadate-induced apoptosis. We also observed that there are some
apoptotic cells in p53-deficient cells, revealing that there may be
some other pathways involved in vanadate-induced apoptosis.

View larger version (33K):
[in this window]
[in a new window]
|
Fig. 8.
Vanadate induces apoptosis in p53+/+ but not
in p53 / fibroblasts. Subconfluent (80-90%) monolayers of
p53+/+ or p53 / fibroblast in 100-mm dishes were subjected to
different concentrations of vanadate for 24 h. The cells were then
harvested, and DNA fragment end labeling assays were performed as
described by using an in situ cell death detection kit. The
cells were analyzed by flow cytometry.
|
|
 |
DISCUSSION |
We reported previously that vanadate can generate ROS, which are
considered to be involved in apoptosis induction (24). However, the
molecular mechanisms of apoptosis caused by vanadate-generated ROS
remain to be investigated. The results presented in this study demonstrate that ROS generated by vanadate mediate p53 activation and
mitochondrial damage, which subsequently leads to cell apoptosis. This
conclusion is based on the observations that exposure of cells to
vanadate resulted in activation of p53 activity, generation of ROS, and
a decrease in mitochondrial transmembrane potential as well as cell
apoptosis. Reduction of vanadate-induced H2O2 by catalase, NAC, or deferoxamine inhibited the p53 activation and cell
mitochondrial damage induced by vanadate. In contrast, increasing
H2O2 generation with SOD or NADPH promoted p53
activation and mitochondrial damage. Furthermore, vanadate-induced
apoptosis occurred at a much higher level in cells expressing wild-type p53 (p53+/+) than in p53-deficient (p53 / ) cells.
It is well accepted that extracellular stimuli trigger signals through
a cascade of protein-protein interactions (1-5, 39-41). It is
generally believed that these extracellular stimuli generate and/or
require reactive free radicals or derived oxidant species to transmit
successfully their signals to the nucleus (40, 42). Naturally occurring
free radicals typically include ROS and reactive nitrogen species (40).
In addition to inducing cellular injury, such as DNA damage and lipid
peroxidation, free radicals also function as intracellular
messengers (19, 40, 43). More and more data are accumulating to
indicate a vital role of ROS in mediating cellular responses by various
extracellular stimuli (19, 24, 26, 32, 40, 43). It has been reported
that free radicals are involved in the production of cytokines, growth factors, and hormones in the activation of nuclear transcription factors, in gene transcription, in neuromodulation, and in
apoptosis (19, 40, 43). For example, it has been reported that
generation of H2O2 is required for
platelet-derived growth factor signal transduction (44). The evidence
suggesting the involvement of ROS in apoptosis includes the following:
1) the addition of ROS or deletion of endogenous antioxidants can
induce apoptosis; 2) apoptosis can be inhibited by endogenous or
exogenous antioxidants in some cases; and 3) apoptosis is associated
with increases in cellular ROS levels (45). Our previous studies have
indicated that vanadate can generate ROS, which are considered to be
involved in apoptosis induction (24). The results presented here
demonstrate that increased intracellular H2O2
levels and activation of p53 activity were detected upon incubation of
cells with vanadate. Pretreatment of cells with NAC or catalase
prevented the increase in ROS and resulted in inhibition of p53
activation by vanadate. In contrast, increasing
H2O2 levels with SOD or NADPH led to higher levels of p53 activation. These data suggest that
H2O2 plays an essential role in
vanadate-induced p53 activation. Although the details of molecular
mechanism for involvement of H2O2 in p53 activation by vanadate are not clear, it is reasonable to hypothesize that H2O2-mediated DNA damage and activation of
other signal transduction pathways, such as mitogen-activated protein
kinase family, may cause an increased p53 protein expression and p53
protein phosphorylation, respectively. It should be noted that
pretreatment of cells with sodium formate enhanced p53 activation by
vanadate. These data are consistent with our previous finding that
sodium formate promotes vanadate-induced apoptosis, supporting our
notion that ·OH is not the positive regulator for p53 activation
by vanadate. The explanation for enhancing effects of vanadate-induced
p53 activation by sodium formate may be due to other pathways by which ·OH feedback down-regulates p53 activation. Our next study will focus on this issue.
Alteration of mitochondrial function has been linked to cell apoptosis
in most cases. An inhibition of oxidative ATP production has been
reported to be associated with glucocorticoid-induced lymphocyte
apoptosis (46). A decrease in the ability of mitochondrial dehydrogenase to cleave tetrazolium salt
(3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide)
has been demonstrated in anti-CD3-induced apoptosis of T cells (33). In
the case of tumor necrosis factor- -induced apoptosis, early
disruption of mitochondrial function has also been described (34).
Detailed study has indicated that alterations of mitochondrial
functions include an early decrease in  m, a drop in the
rate of mitochondrial translation and defect in mitochondrial protein
cytoplasmic precursor maturation (47). Among all of these changes, the
decrease in  m may be most tightly associated with cell
apoptosis. Indeed, overexpression of Bcl-2 or treatment of cells with
ionophore nigericin resulted in both an increase in  m and
the inhibition of apoptosis (48). The data from the current
investigation demonstrate a drop in  m after exposure of
cells to vanadate. This alteration of mitochondrial function could be
blocked by either scavenging H2O2 or deletion
of the p53 gene. These data therefore indicate that generation of ROS
is required for vanadate-induced mitochondrial damage.
Apoptosis is a naturally occurring process of cell "suicide" that
plays a critical role in the development and maintenance of metazoans
by eliminating superfluous or unwanted cells (1-4, 11-12). Disruption
of apoptosis plays a major role in diseases such as cancer, AIDS,
autoimmune disease, and neurodegeneration (11-18). The biochemical
machinery for apoptotic cell death is constitutively present in
virtually all mammalian cells and can be activated by a wide variety of
extra- or intracellular signals (1-6, 24). Although numerous
investigations have been dedicated to the elucidation of apoptosis
initiation and regulation, fundamental questions concerning the
molecular and biochemical mechanisms of apoptosis elicited by different
stimuli remain to be understood. Vanadate has been reported to be an
agent with potent toxic effects in a wide variety of experimental
systems (21-24). It has been shown to cause DNA mutations and
DNA-protein cross-links and apoptosis (21-24). Some previous
studies have suggested that vanadium-mediated generation of ROS may be
involved in toxicity and apoptosis induced by this metal (24-27). In
the present investigation, we demonstrated that through
H2O2-mediated reaction vanadate is able to
cause p53 activation, which is required for apoptosis induction by vanadate.
In summary, the results presented in the present study demonstrate that
vanadate induces generation of H2O2, which is
required for p53 transactivation. This
H2O2-mediated p53 activation appears to play an
essential role in vanadate-induced apoptosis.
 |
FOOTNOTES |
*
The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
¶
To whom correspondence should be addressed: Health Effects
Laboratory Division, NIOSH, Morgantown, WV 26505. Tel.: 304-285-6158; Fax: 304-285-5938; E-mail: xas0@cdc.gov.
Published, JBC Papers in Press, August 1, 2000, DOI 10.1074/jbc.M005366200
 |
ABBREVIATIONS |
The abbreviations used are:
ROS, reactive oxygen
species;
NAC, N-acetyl-L-cysteine;
SOD, superoxide dismutase;
DiOC6, 3,3'-dihexyloxacarbocyanine
iodide;
DCFH-DA, 2',7'-dichlorofluorescin diacetate;
HE, dihydroethidium;
FBS, fetal bovine serum;
MEM, Eagle's minimal
essential medium;
PBS, phosphate-buffered saline.
 |
REFERENCES |
| 1.
|
Steller, H.
(1995)
Science
267,
1445-1449
|
| 2.
|
Martin, S. J.,
and Green, D. R.
(1995)
Cell
82,
349-352
|
| 3.
|
Raff, M. C.
(1992)
Science
356,
397-400
|
| 4.
|
Ellis, R. E.,
Yuan, J.,
and Horvitz, H. R.
(1991)
Annu. Rev. Cell Biol.
7,
663-698
|
| 5.
|
Huang, C.,
Ma, W.-Y.,
Li, J.,
Hecht, S. S.,
and Dong, Z.
(1998)
Cancer Res.
58,
4102-4106
|
| 6.
|
Huang, C.,
Ma, W.-Y.,
and Dong, Z.
(1999)
Carcinogenesis
20,
237-242
|
| 7.
|
Liebermann, D. A.,
Hoffman, B.,
and Steinman, R. A.
(1995)
Oncogene
11,
199-210
|
| 8.
|
Huang, C.,
Ma, W.-Y.,
Maxiner, A.,
Sun, Y.,
and Dong, Z.
(1999)
J. Biol. Chem.
274,
12229-12235
|
| 9.
|
Adler, V.,
Pincus, M. R.,
Minamoto, T.,
Fuchs, S. Y.,
Bluth, M. J.,
Brandt-Rauf, P. W.,
Friedman, F. K.,
Robinson, R. C.,
Chen, J. M.,
Wang, X. W.,
Harris, C. C.,
and Ronai, Z.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
1686-1691
|
| 10.
|
Meek, D. W.,
Campbell, L. E.,
Jardine, L. J.,
Knippschild, U.,
Mckendrick, L.,
and Milne, M.
(1997)
Biochem. Soc. Trans.
25,
416-419
|
| 11.
|
White, E.
(1996)
Genes Dev.
10,
1-15
|
| 12.
|
Wyllie, A. H.,
Kerr, F. R.,
and Currie, A. R.
(1980)
Int. Rev. Cytol.
68,
251-270
|
| 13.
|
Allen, P. D.,
Bustin, S. A.,
and Newland, A. C.
(1993)
Blood Rev.
7,
63-73
|
| 14.
|
Cohen, J. J.,
and Duke, R. C.
(1992)
Annu. Rev. Immunol.
10,
267-293
|
| 15.
|
Clarke, P. G. H.
(1990)
Anat. Embryol.
181,
195-213
|
| 16.
|
Carson, D. A.,
and Ribero, J. M.
(1993)
Lancet
34,
1251-1254
|
| 17.
|
Edington, S. M.
(1993)
Bio/Technology
11,
787-792
|
| 18.
|
Gougeon, M. L.,
and Montagnier, L.
(1993)
Science
260,
1269-1270
|
| 19.
|
Ding, M.,
Li, J.-J.,
Leonard, S. S.,
Ye, J.-P.,
Shi, X.,
Colburn, N. H.,
Castranova, V.,
and Vallyathan, V.
(1999)
Carcinogenesis
20,
663-668
|
| 20.
|
Nriagu, J. O.,
and Pacyna, J. M.
(1988)
Nature
333,
134-139
|
| 21.
|
Huang, C.,
Chen, N.,
Ma, W.-Y.,
and Dong, Z.
(1998)
Int. J. Oncol.
13,
711-715
|
| 22.
|
Cohen, M. D.,
Klein, C. B.,
and Costa, M.
(1992)
Mutat. Res.
269,
141-148
|
| 23.
|
Sheu, C. W.,
Rodriguez, I.,
and Lee, J. K.
(1992)
Food Chem. Toxicol.
30,
307-311
|
| 24.
|
Ye, J.-P.,
Ding, M.,
Leonard, S. S.,
Robinson, V. A.,
Millecchia, L.,
Zhang, X.,
Castranova, V.,
Vallyathan, V.,
and Shi, X.
(1999)
Mol. Cell. Biochem.
202,
9-17
|
| 25.
|
Stohs, S. J.,
and Bagchi, D.
(1995)
Free Radic. Biol. Med.
18,
321-336
|
| 26.
|
Shi, X.,
and Dalal, N. S.
(1992)
Free Radic. Res. Commun.
17,
369-376
|
| 27.
|
Parfett, C. L. J.,
and Pilon, R.
(1995)
Food Chem. Toxicol.
33,
301-308
|
| 28.
|
Huang, C.,
Ma, W.,
and Dong, Z.
(1996)
Mol. Cell. Biol.
16,
6427-6435
|
| 29.
|
Huang, C.,
Schmid, P. C.,
Ma, W.-Y.,
Schmid, H. H. O.,
and Dong, Z.
(1997)
J. Biol. Chem.
272,
4187-4194
|
| 30.
|
Huang, C.,
Ma, W.-Y.,
Ryan, C. A.,
and Dong, Z.
(1997)
Proc. Natl. Acad. Sci. U. S. A.
94,
11957-11962
|
| 31.
|
Harvey, M.,
Sands, A. T.,
Weiss, R. S.,
Hegi, M. E.,
Wiseman, R. W.,
Pantazis, P.,
Giovanella, B. C.,
Tainsky, M. A.,
Bradley, A.,
and Donehower, L. A.
(1993)
Oncogene
8,
2457-2467
|
| 32.
|
Ye, J.,
Wang, S.,
Leonard, S. S.,
Sun, Y.,
Butterworth, L.,
Antonini, J.,
Ding, M.,
Rojanasakul, Y.,
Vallyathan, V.,
Castranova, V.,
and Shi, X.
(1999)
J. Biol. Chem.
274,
34974-34980
|
| 33.
|
Mosman, T.
(1983)
J. Immunol. Methods
65,
55-63
|
| 34.
|
Schulze-Osthoff, K.,
Bakker, A. C.,
Vanhaesebroeck, B.,
Beyaert, R.,
Jacob, W. A.,
and Fiers, W.
(1992)
J. Biol. Chem.
267,
5317-5323
|
| 35.
|
Chen, Z. P.,
and Yeung, D. C.
(1996)
Mol. Biol. Int.
38,
607-616
|
| 36.
|
Yin, X.,
Davison, A. J.,
and Tsang, S. S.
(1992)
Biochem. Mol. Cell. Biochem.
115,
85-96
|
| 37.
|
Clarke, A. R.,
Gledhill, S.,
Hooper, M. L.,
Bird, C. C.,
and Wyllie, A. H.
(1994)
Oncogene
9,
1767-1773
|
| 38.
|
McCarthy, S. A.,
Symonds, H. S.,
and Van-Dyke, T.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
3979-3983
|
| 39.
|
Huang, C.,
Ma, W.,
Bowden, G. T.,
and Dong, Z.
(1996)
J. Biol. Chem.
49,
31262-31268
|
| 40.
|
Lander, H. M.
(1997)
FASEB J.
11,
118-124
|
| 41.
|
Huang, C.,
Ma, W.,
Ding, M.,
Bowden, G. T.,
and Dong, Z.
(1997)
J. Biol. Chem.
272,
27753-27757
|
| 42.
|
Polyak, K.,
Xia, Y.,
Zweier, J. L.,
Kinzler, K. W.,
and Vogelstein, B.
(1997)
Nature
389,
300-305
|
| 43.
|
Sen, C. K.,
and Packer, L.
(1996)
FASEB J.
10,
709-720
|
| 44.
|
Sundaresan, M., Yu, Z.-X.,
Ferrans, V. J.,
Irani, K.,
and Finkel, T.
(1995)
Science
270,
296-299
|
| 45.
|
Petit, P. X.,
Susin, S.-A.,
Zamzami, N.,
Mignotte, B.,
and Kroemer, G.
(1996)
FEBS Lett.
396,
7-13
|
| 46.
|
Nordeen, S. K.,
and Young, D. A.
(1976)
J. Biol. Chem.
251,
7295-7303
|
| 47.
|
Vayssiere, J. L.,
Petit, P. X.,
Risler, Y.,
and Mignotte, B.
(1994)
Proc. Natl. Acad. Sci. U. S. A.
91,
11752-11756
|
| 48.
|
Hennet, T.,
Bertoni, G.,
Richter, C.,
and Oeterhans, F.
(1993)
Cancer Res.
53,
1456-1460
|
Copyright © 2000 by The American Society for Biochemistry and Molecular Biology, Inc.

CiteULike Complore Connotea Del.icio.us Digg Reddit Technorati What's this?
This article has been cited by other articles:

|
 |

|
 |
 
O. M. Lukandu, D. E. Costea, E. Neppelberg, A. C. Johannessen, and O. K. Vintermyr
Khat (Catha edulis) Induces Reactive Oxygen Species and Apoptosis in Normal Human Oral Keratinocytes and Fibroblasts
Toxicol. Sci.,
June 1, 2008;
103(2):
311 - 324.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
D. Zhang, L. Song, J. Li, K. Wu, and C. Huang
Coordination of JNK1 and JNK2 Is Critical for GADD45{alpha} Induction and Its Mediated Cell Apoptosis in Arsenite Responses
J. Biol. Chem.,
November 10, 2006;
281(45):
34113 - 34123.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
Y. Hasegawa, M. Morioka, S. Hasegawa, J. Matsumoto, T. Kawano, Y. Kai, S. Yano, K. Fukunaga, and J.-i. Kuratsu
Therapeutic Time Window and Dose Dependence of Neuroprotective Effects of Sodium Orthovanadate following Transient Middle Cerebral Artery Occlusion in Rats
J. Pharmacol. Exp. Ther.,
May 1, 2006;
317(2):
875 - 881.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Rivera and S. A. Maxwell
The p53-induced Gene-6 (Proline Oxidase) Mediates Apoptosis through a Calcineurin-dependent Pathway
J. Biol. Chem.,
August 12, 2005;
280(32):
29346 - 29354.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
L. Wang, L. Bowman, Y. Lu, Y. Rojanasakul, R. R. Mercer, V. Castranova, and M. Ding
Essential role of p53 in silica-induced apoptosis
Am J Physiol Lung Cell Mol Physiol,
March 1, 2005;
288(3):
L488 - L496.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
M. Holgado-Madruga and A. J. Wong
Gab1 Is an Integrator of Cell Death versus Cell Survival Signals in Oxidative Stress
Mol. Cell. Biol.,
July 1, 2003;
23(13):
4471 - 4484.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
A. Tardif, N. Julien, J.-L. Chiasson, and L. Coderre
Stimulation of glucose uptake by chronic vanadate pretreatment in cardiomyocytes requires PI 3-kinase and p38 MAPK activation
Am J Physiol Endocrinol Metab,
June 1, 2003;
284(6):
E1055 - E1064.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
S. A. Maxwell and A. Rivera
Proline Oxidase Induces Apoptosis in Tumor Cells, and Its Expression Is Frequently Absent or Reduced in Renal Carcinomas
J. Biol. Chem.,
March 7, 2003;
278(11):
9784 - 9789.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Luo, Y. Sun, H. Lin, Y. Qian, Z. Li, S. S. Leonard, C. Huang, and X. Shi
Activation of JNK by Vanadate Induces a Fas-associated Death Domain (FADD)-dependent Death of Cerebellar Granule Progenitors in Vitro
J. Biol. Chem.,
February 7, 2003;
278(7):
4542 - 4551.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
J. Bai and A. I. Cederbaum
Catalase Protects HepG2 Cells from Apoptosis Induced by DNA-damaging Agents by Accelerating the Degradation of p53
J. Biol. Chem.,
February 7, 2003;
278(7):
4660 - 4667.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
H. Zhang, X. Shi, Q.-J. Zhang, M. Hampong, H. Paddon, D. Wahyuningsih, and S. Pelech
Nocodazole-induced p53-dependent c-Jun N-terminal Kinase Activation Reduces Apoptosis in Human Colon Carcinoma HCT116 Cells
J. Biol. Chem.,
November 8, 2002;
277(46):
43648 - 43658.
[Abstract]
[Full Text]
[PDF]
|
 |
|

|
 |

|
 |
 
T. Fujita, M. Maruyama, J. Araya, K. Sassa, Y. Kawagishi, R. Hayashi, S. Matsui, T. Kashii, N. Yamashita, E. Sugiyama, et al.
Hydrogen Peroxide Induces Upregulation of Fas in Human Airway Epithelial Cells via the Activation of PARP-p53 Pathway
Am. J. Respir. Cell Mol. Biol.,
November 1, 2002;
27(5):
542 - 552.
[Abstract]
[Full Text]
| |